Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Validation of an Arabic version of Fatigue Severity Scale.
DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications.
Visual Evoked Potential and Magnetic Resonance Imaging are More Effective Markers of Multiple Sclerosis Progression than Laser Polarimetry with Variable Corneal Compensation.
Insights into multiple sclerosis provided by non-coding RNAs: meeting summary from the symposium 'Non-coding RNAs in autoimmune disorders of the central nervous system' on 5 April 2013 in Warsaw, Poland.
CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2.
The Relationship Between Quality of Life and Dysarthria in Patients with Mutliple Sclerosis.
Cerebrospinal fluid inflammatory markers in patients with multiple sclerosis: a pilot study.
Aquaporin-4 autoimmunity masquerading as a brainstem tumor.
Meningeal inflammation and demyelination in a patient clinically diagnosed with acute disseminated encephalomyelitis.
Psychiatric symptoms accompanying multiple sclerosis onset: a case report.
Occurrence of Psoriatic Arthritis during Interferon Beta 1a Treatment for Multiple Sclerosis.
Children and adolescents adjustment to parental multiple sclerosis: a systematic review.
How reliable is the classification of cognitive impairment across different criteria in early and late stages of multiple sclerosis?
Autoantibodies in pre-clinical autoimmune disease.
Psychiatric diagnoses, medication and risk for disability pension in multiple sclerosis patients; a population-based register study.
Could antiretroviral drugs be effective in multiple sclerosis? A case report.
Sound Lateralization Test Distinguishes Unimpaired MS Patients from Healthy Controls.
Correction: Intrathecal Infusion of Hydrogen-Rich Normal Saline Attenuates Neuropathic Pain via Inhibition of Activation of Spinal Astrocytes and Microglia in Rats.
Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-κB activation.
Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis.
Multiple sclerosis and susceptibility to cardiovascular diseases: Implications of ethnicity-related interleukin-17A gene polymorphism?
Detection of B-cell populations with monotypic light chain expression in cerebrospinal fluid specimens from patients with multiple sclerosis by polychromatic flow cytometry.
Can somatosensory evoked potentials predict disease course in early multiple sclerosis patients?
Epidemiology and clinical record of multiple sclerosis in selected countries - a systematic review.
[Teriflunomide is a new peroral disease-modifying drug for multiple sclerosis (a review)].
Pages
« first
‹ previous
…
463
464
465
466
467
468
469
470
471
…
next ›
last »